Registration and Activity Links - HIV/AIDS
Audio Journal of AIDS Management
The Audio Journal of AIDS Management (AJAM) is a multidisciplinary electronic journal available on audiotape, CD, and via the Internet that brings physicians the latest developments in the field of HIV/AIDS. Each issue of AJAM features 4-6 segments by leading experts on a wide range of topics of interest to practitioners. The AJAM Editorial Board is chaired by Bruce W. Polsky, MD, Chief of Infectious Diseases at St. Luke's-Roosevelt Hospital in New York City.
Past AJAM segments have included the world’s most renowned clinicians and researchers, such as Anthony Fauci, Robert Gallo, Luc Montagnier, Paul Volberding, and Jonas Salk. The following are a few of the topics covered since the AJAM service began in the late 1980s.
Access to Treatment in Developing Countries
Adherence and Patient Compliance
AIDS in Africa and the Global Threat of HIV
AIDS: New York City Experience and Perspectives
Antiretoviral Therapy at the Millennium: Current Strategies, Future Challenges
Beginning of Life Issues
Coinfection with hepatitis B and C
Community-based Research Initiatives
Current Principles of Salvage Therapy
Drug Resistance to Anti-CMV Agents in CMV Retinitis
Emerging Antiretroviral Therapies
Experimental and Licensed HIV Treatment for Asymptomatic Patients
Frequency of Viral Load Monitoring
Fusion Inhibitors from Japan
Global Views: The Multisectoral Approach to AIDS Control in Uganda
Hairy Leukoplakia as a Prognostic Marker of Disease Progression
Healthcare Workers and HIV: Defining the Risk
Hepatitis and HIV Coinfection
HIV and Intestinal Disease
HIV Disease in Women
HIV Infection in Prisons
HIV Managed Care Systems
HIV Prevention: Efforts for Intravenous Drug Users
Hydroxyurea and Intensification
Immune Reconstitution
Improving Adherence to Therapy
Improving Patient Compliance
International Conference Coverage
Managing AIDS-related Diarrhea Prophylaxis for Opportunistic Infections
Managing Pediatric HIV Infection
Metabolic Changes and Lipodystrophy
Neuropathies in HIV Disease
New Drugs on the Horizon
New Protease Inhibitors in Development
New Strategies for Reducing Perinatal Transmission
Once-Daily Treatments
Opportunistic Infections in the Age of Antiretroviral Therapy
Patterns of Care and Cost in the Era of HAART
Post-Exposure Prophylaxis
Post-Exposure Prophylaxis Following Unsafe Sex
Predictive Value of HIV Phenotypic Susceptibility Testing
Prescribing Patterns of U.S. Physicians
Preventing Mother-to-Child Transmission
Progress Toward an HIV Vaccine
Replacing the Ganciclovir Eye Implant in the Era of HAART
Resistance Issues
Resistance Testing and Salvage Therapy
Resistance Testing: Which Test May Be Better
Risk of Heterosexual HIV Infection
Second-Generation Protease Inhibitors
Society’s Response to Advances in HIV Treatment
Starting Therapy: Controversial New Guidelines
STI: Is It Ready for Prime Time?
Stopping Secondary Prophylaxis of Opportunistic Infections
Strategies for Enduring Antiretoviral Therapy
Strategies in Combination Therapy
Structured Treatment Interruption
Switching Strategies for Managing Lipodystrophy and Metabolic Abnormalities
The Latest on Metabolic Complications
The Multi-Center AIDS Cohort Study
The Potential of Therapeutic Drug Monitoring
The Role of Resistance Testing in Clinical Practice
Tuberculosis in the Age of AIDS: Management and Prevention
Update on the Atlantic Trial
Vaccine Development
Viral Testing in CMV Disease
Whatever Happened to HIV Dementia?
Women and HIV/AIDS
To join the AJAM mailing list, please send your name, specialty, phone number, address, and e-mail to info@ncme.com
For information on sponsoring AJAM, contact:
info@ncme.com